Empower Advisory Group
IDXX icon

Empower Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Empower Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
818
+37
+5% +$20.8K ﹤0.01% 367
2026
Q1 		$439K Sell
781
-559
-42% -$358K ﹤0.01% 345
2025
Q4 		$907K Buy
1,340
+557
+71% +$379K ﹤0.01% 257
2025
Q3 		$500K Buy
783
+7
+0.9% +$4.25K ﹤0.01% 345
2025
Q2 		$416K Sell
776
-7
-0.9% -$3.35K ﹤0.01% 349
2025
Q1 		$329K Buy
783
+1
+0.1% +$434 ﹤0.01% 385
2024
Q4 		$323K Sell
782
-44
-5% -$19.3K ﹤0.01% 389
2024
Q3 		$417K Sell
826
-3
-0.4% -$1.46K ﹤0.01% 347
2024
Q2 		$404K Sell
829
-10
-1% -$5.02K ﹤0.01% 341
2024
Q1 		$453K Sell
839
-7
-0.8% -$3.83K ﹤0.01% 318
2023
Q4 		$470K Buy
846
+12
+1% +$5.63K ﹤0.01% 306
2023
Q3 		$365K Hold
834
– – ﹤0.01% 338
2023
Q2 		$419K Sell
834
-57
-6% -$27.3K ﹤0.01% 333
2023
Q1 		$436K Buy
+891
New +$426K ﹤0.01% 329

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Empower Advisory Group's IDXX Position: Q2 2026 in Review

Empower Advisory Group increased its Idexx Laboratories (IDXX) stake by 4.7% in Q2 2026, buying an estimated $20.8K and bringing the position to 818 shares worth $431K. The position accounts for ﹤0.01% of the portfolio, ranked #367.

Empower Advisory Group first reported a position in IDXX in Q1 2023 and has held it in 14 quarters since. The position peaked at $907K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Empower Advisory Group held 818 shares of Idexx Laboratories worth $431K as of Q2 2026.
  • Empower Advisory Group bought 37 Idexx Laboratories shares in Q2 2026, an estimated $20.8K.
  • Idexx Laboratories made up ﹤0.01% of Empower Advisory Group's portfolio in Q2 2026, its #367 holding.
  • Empower Advisory Group first reported a position in Idexx Laboratories in Q1 2023 and has held it in 14 quarters since.
  • Empower Advisory Group's Idexx Laboratories position peaked at $907K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Empower Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.